BiotechTube
Home/Incannex Healthcare/Joel Latham
JL

Joel Latham

Managing Director and CEO

Incannex Healthcare

Therapeutic Areas

Sleep DisordersPsychiatryInflammatory Diseases

Incannex Healthcare Pipeline

DrugIndicationPhase
IHL-42XObstructive Sleep Apnea (OSA)Phase 2/3
Psi-GADGeneralized Anxiety Disorder (GAD)Phase 2
IHL-675AInflammatory Lung Conditions (e.g., ARDS, COPD)Preclinical / Phase 1

Leadership Team at Incannex Healthcare

SB
Stephen Bond
Chief Financial Officer
MB
Mark Bleackley
Chief Scientific Officer
View full Incannex Healthcare profile